About us
- API
- Ivabradine hydrochlorid
- Rivaroxaban
- Apixaban
- Dabigatran etexilate
- Safinamide
- Ticlopidine hydrochloride
- Mirtazapine
- Clopidogrel bisulfate
- Duloxetine hydrochloride
- Rebamipide
- Intermediates
- Duloxetine intermediate
- Clopidogrel intermediate
- Mirtazapine intermediates
- Dabigatran etexilate intermediates
- Lurasidone intermediates
- Bepotastine intermediates
- Asenapine Intermediates
- Drotaverine intermediates
- Prasugrel Intermediates
- Ivabradine、Verapamil, Denopamine intermediates
- Moxifloxacin intermediate
- Ticagrelor intermediate <Under Development>
- Canagliflozin intermediate
- Ivabradine intermediate
Address: Zhejiang Provincial Chemical and Medical Raw Material Base Linhai Zone, Duqiao Town, Linhai City, Zhejiang Province, 317016, China
Tel / Fax: 0576-85588211
Tel / Fax: 0576-85588211
Product
Dabigatran etexilate intermediates
Product Name | Structure | CAS No. | Specification | Category |
3-[(3-Amino-4-methylaminobenzoyl)pyridin-2-ylamino]propionic acid ethyl ester | 212322-56-0 | Assay:≥95% Impurity:≤5.0% | Dabigatran etexilate intermediates | |
2-(4-Cyanophenylamino)acetic acid | 42288-26-6 | Assay:≥99% Impurity:≤1.0% | Dabigatran etexilate intermediates | |
Ethyl 3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino] propionate | 211915-84-3 | Assay:≥95% Impurity:≤5.0% | Dabigatran etexilate intermediates | |
N-[[2-[[[4-(aminomethyl)amino]methl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride | 211914-50-0 | In-house | Dabigatran etexilate intermediates |